Variable | Study hospitals, n (%) | Total, n (%) | |||
---|---|---|---|---|---|
DTCSH | NMWH | ADZH | MEYH | ||
Hypertension specific regimen complexity | |||||
 Low | 67 (44.7) | 59 (59) | 65 (65) | 45 (61.6) | 236 (55.8) |
 Moderate | 77 (51.3) | 37 (37) | 34 (34) | 25 (34.3) | 173 (40.9) |
 High | 6 (4) | 4 (4) | 1 (1) | 3 (4.1) | 14 (3.3) |
Patient level regimen complexity | |||||
 Low total | 22 (14.7) | 15 (15) | 34 (34) | 16 (21.9) | 87 (20.5) |
 Moderate total | 71 (47.3) | 40 (40) | 37 (37) | 41 (56.2) | 189 (44.7) |
 High total | 57 (38) | 45 (45) | 29 (29) | 16 (21.9) | 147 (34.8) |
Medication adherence | |||||
 Adherent | 83 (55.3) | 18 (18) | 56 (56) | 3 (4.1) | 160 (37.8) |
 Non adherent | 67 (44.7) | 82 (82) | 44 (44) | 70 (95.9) | 263 (62.2) |
Blood pressure control | |||||
 Controlled | 47 (31.3) | 31 (31) | 72 (72) | 25 (34.3) | 175 (41.37) |
 Uncontrolled | 103(68.7) | 69 (69) | 28 (28) | 48 (65.8) | 248 (58.63) |
Number of antihypertensive drug | |||||
 Monotherapy | 67 (44.7) | 58 (58) | 57 (57) | 42 (57.5) | 224 (52.9) |
 Dual therapy | 69 (46) | 38 (38) | 39 (39) | 23 (31.5) | 169 (40) |
 Three or more | 14 (9.3) | 4 (4) | 4 (4) | 8 (10) | 30 (7.1) |
Drug selection | |||||
 Effective | 124 (82.7) | 87 (87) | 85 (85) | 52 (71.2) | 348 (82.3) |
 Ineffective | 26 (17.3) | 13 (13) | 15 (15) | 21(28.8) | 75 (17.7) |
Drug-drug interaction | |||||
 No interaction | 88 (58.7) | 67 (67) | 70 (70) | 54 (74) | 279 (66) |
 Moderate | 44 (29.3) | 19 (19) | 22 (22) | 18 (24.7) | 103 (24.3) |
 Major | 18 (12) | 14 (14) | 8 (8) | 1 (1.4) | 41 (9.7) |
Dose | |||||
 Normal | 147 (98) | 98 (98) | 100 (100) | 72 (98.6) | 417 (98.6) |
 Too low | 2 (1.3) | 2 (2) | 0 (0) | 0 (0) | 4 (0.9) |
 Too high | 1 (0.7) | 0 (0) | 0 (0) | 1 (1.4) | 2 (0.5) |